Active Ingredient History
Coenzyme Q, also known as ubiquinone and marketed as CoQ10, is a coenzyme family that is ubiquitous in animals and most bacteria (hence the name ubiquinone). In humans, the most common form is coenzyme Q10 or ubiquinone-10. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Absorption (Phase 1)
Aging (Phase 2)
Alzheimer Disease (Phase 1)
Amyotrophic Lateral Sclerosis (Phase 2)
Astrocytoma (Phase 1)
Ataxia (Phase 1)
Atherosclerosis (Phase 4)
Bipolar Disorder (Phase 2)
Blood (Phase 1)
Breast Neoplasms (Phase 1)
Burns (Early Phase 1)
Carcinoma, Basal Cell (Phase 2)
Carcinoma, Hepatocellular (Phase 2/Phase 3)
Carcinoma, Squamous Cell (Phase 2)
Cardiomyopathy, Dilated (Phase 4)
Cardiovascular Diseases (Phase 4)
Charcot-Marie-Tooth Disease (Phase 1/Phase 2)
Colitis, Ulcerative (Phase 2)
Coronary Artery Disease (Phase 3)
Coronary Stenosis (Phase 3)
COVID-19 (Phase 2)
Death, Sudden, Cardiac (Phase 2)
Depression (Phase 2)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 1 (Phase 2)
Diabetes Mellitus, Type 2 (Phase 2)
Diabetic Retinopathy (Phase 2)
Drugs, Investigational (Phase 4)
Dyslipidemias (Phase 3)
Fatigue (Phase 1/Phase 2)
Fatigue Syndrome, Chronic (Phase 2/Phase 3)
Frailty (Phase 2)
Glaucoma, Open-Angle (Phase 4)
Glioblastoma (Phase 1)
Gliosarcoma (Phase 1)
Healthy Volunteers (Phase 4)
Heart Arrest (Phase 2)
Heart Failure (Phase 1)
Heart Failure, Diastolic (Phase 4)
Huntington Disease (Phase 3)
Hypercholesterolemia (Phase 4)
Hypertension (Phase 1)
Hypertension, Pulmonary (Phase 1)
Infertility (Phase 4)
Inflammation (Phase 4)
Kidney Failure, Chronic (Phase 4)
Lichen Planus, Oral (Phase 1)
Metabolic Syndrome (Phase 2)
Metabolism (Phase 4)
Mitochondrial Diseases (Phase 3)
Multiple Organ Failure (Phase 3)
Multiple Sclerosis (Phase 1/Phase 2)
Muscle Cramp (Phase 2/Phase 3)
Muscle Weakness (Phase 4)
Muscular Dystrophies, Limb-Girdle (Phase 2/Phase 3)
Muscular Dystrophy, Duchenne (Phase 3)
Myalgia (Phase 4)
Myelodysplastic Syndromes (Phase 2/Phase 3)
Myocardium (Early Phase 1)
Neoplasms (Phase 1)
Nervous System Diseases (Phase 2/Phase 3)
Osteoporosis (Phase 2)
Pain (Phase 2/Phase 3)
Parkinson Disease (Phase 3)
Pharmacology (Phase 1)
Prader-Willi Syndrome (Phase 3)
Pre-Eclampsia (Phase 3)
Pulmonary Disease, Chronic Obstructive (Phase 2)
Quality of Life (Phase 1/Phase 2)
Renal Dialysis (Phase 4)
Renal Insufficiency, Chronic (Phase 4)
Sarcopenia (Phase 2)
Skin Care (Early Phase 1)
Sleep Apnea Syndromes (Early Phase 1)
Spinal Cord Injuries (Phase 2)
Supranuclear Palsy, Progressive (Phase 2/Phase 3)
Vascular Calcification (Phase 3)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue